PGEN
Price
$1.32
Change
-$0.05 (-3.62%)
Updated
May 8, 2:23 PM EST
One day until earnings call
VERV
Price
$6.21
Change
+$0.04 (+0.65%)
Updated
May 8, 9:35 AM EST
92 days until earnings call
Ad is loading...

PGEN vs VERV

Header iconPGEN vs VERV Comparison
Open Charts PGEN vs VERVBanner chart's image
Precigen
Price$1.32
Change-$0.05 (-3.62%)
Volume$300
CapitalizationN/A
Verve Therapeutics
Price$6.21
Change+$0.04 (+0.65%)
Volume$5.06K
CapitalizationN/A
View a ticker or compare two or three
PGEN vs VERV Comparison Chart

Loading...

PGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VERVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PGEN vs. VERV commentary
May 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a Hold and VERV is a Hold.

COMPARISON
Comparison
May 08, 2024
Stock price -- (PGEN: $1.38 vs. VERV: $6.16)
Brand notoriety: PGEN and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 106% vs. VERV: 67%
Market capitalization -- PGEN: $350.86M vs. VERV: $517.38M
PGEN [@Biotechnology] is valued at $350.86M. VERV’s [@Biotechnology] market capitalization is $517.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, PGEN is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • PGEN’s TA Score: 3 bullish, 4 bearish.
  • VERV’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VERV is a better buy in the short-term than PGEN.

Price Growth

PGEN (@Biotechnology) experienced а +4.55% price change this week, while VERV (@Biotechnology) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.03%. For the same industry, the average monthly price growth was -4.77%, and the average quarterly price growth was +71.17%.

Reported Earning Dates

PGEN is expected to report earnings on Aug 05, 2024.

VERV is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PGEN with price predictions.
OPEN
A.I.dvisor published
a Summary for VERV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VERV($517M) has a higher market cap than PGEN($351M). PGEN YTD gains are higher at: 2.985 vs. VERV (-55.811).
PGENVERVPGEN / VERV
Capitalization351M517M68%
EBITDAN/AN/A-
Gain YTD2.985-55.811-5%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
PGENVERV
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 7 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
PGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VERVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPVIX19.470.07
+0.36%
Timothy Plan Small Cap Value I
TSOPX13.530.02
+0.15%
Nuveen International Res Eq Prmr
GPGOX3.48N/A
N/A
Grandeur Peak Global Opportunities Inv
LGCYX15.66N/A
N/A
Lord Abbett Global Equity I
JMIEX31.16-0.02
-0.06%
JPMorgan Emerging Markets Equity L

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-3.90%
BEAM - VERV
61%
Loosely correlated
-1.10%
NTLA - VERV
58%
Loosely correlated
+0.67%
PGEN - VERV
47%
Loosely correlated
-4.17%
PRME - VERV
47%
Loosely correlated
+3.15%
GRTS - VERV
46%
Loosely correlated
+5.01%
More